COP
57
-2
LH
40
-5
ABT
59
2
SWK
50
-5
AEP
54
6
AMAT
33
-13
XYL
35
-2
AA
56
15
BDX
56
10
CVX
43
-3
CNP
54
10
CCI
30
-11
BA
47
2
MS
77
-2
PAYX
48
-6
NWSA
62
-7
BK
74
3
ORLY
60
-5
ROST
57
-3
SIG
44
-3
COP
57
-2
LH
40
-5
ABT
59
2
SWK
50
-5
AEP
54
6
AMAT
33
-13
XYL
35
-2
AA
56
15
BDX
56
10
CVX
43
-3
CNP
54
10
CCI
30
-11
BA
47
2
MS
77
-2
PAYX
48
-6
NWSA
62
-7
BK
74
3
ORLY
60
-5
ROST
57
-3
SIG
44
-3
Financhill
Back

BondBloxx CCC Rated USD HY Corp Bd ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
72

XCCC
BondBloxx CCC Rated USD HY Corp Bd ETF

Last Price:
39.40
Seasonality Move:
3.68%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
72
BondBloxx CCC Rated USD HY Corp Bd ETF (XCCC) is a Buy

Is BondBloxx CCC Rated USD HY Corp Bd ETF a Buy, Sell or Hold?

  • The current BondBloxx CCC Rated USD HY Corp Bd ETF [XCCC] share price is $39.48. The Score for XCCC is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • XCCC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XCCC Stock Price Chart

What is BondBloxx CCC Rated USD HY Corp Bd ETF's stock price today?

  • The BondBloxx CCC Rated USD HY Corp Bd ETF share price today is $39.48
    The current trend is moderately bearish and XCCC is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

XCCC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 51.48 Buy
Chaikin Money Flow: 18862 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.36 - 39.62) Sell
Bollinger Bands (100): (37.79 - 39.51) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

XCCC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.53 Sell
20-day SMA: 39.48 Sell
50-day SMA: 39.42 Buy
200-day SMA: 38.37 Buy
8-day EMA: 39.49 Sell
20-day EMA: 39.47 Buy
50-day EMA: 39.27 Buy
200-day EMA: 38.49 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

BondBloxx CCC Rated USD HY Corp Bd ETF Earnings Growth & XCCC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

BondBloxx CCC Rated USD HY Corp Bd ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):